Arkolith/Insider Trading/ELVN/Form 4

Hohl Benjamin

CHIEF FINANCIAL OFFICEREnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Jul 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$317K
Net Open-Market Flow
-$317K
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2026Option exercise(M)1K$2.48$3K52K
Jul 17, 2026Sell(S)324$49.97$16K52K
Jul 17, 2026Sell(S)369$51.48$19K51K
Jul 17, 2026Sell(S)3K$52.32$134K49K
Jul 17, 2026Sell(S)3K$53.38$141K46K
Jul 17, 2026Sell(S)123$53.87$7K46K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 17, 2026Option exercise(M)1K—$085K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001882764-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Enliven Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp